Maximus vs Hone Health
Side by side, from each clinic's published information. No winner is declared; it depends on your goals and your doctor's advice.
| Maximus | Hone Health | |
|---|---|---|
| Monthly price by therapy | Enclomiphene $199.99 (1-mo) / $149.99 (3-mo) / $99.99 (6 or 12-mo); Injectable TRT $199.99/$149.99/$99.99; Oral TRT $249.99/$199.99/$149.99; Topical TRT $199.99/$149.99/$99.99; Injectable TRT+HCG $399.98/$349.98/$299.98 [vendor 2026-10-25] | Basic membership $25/mo or Premium $155/mo, plus medication [vendor 2026-10-25]; enclomiphene med from $42/mo (≈$197/mo all-in on Premium; Kymata, unverified 2026-10-25) |
| Fertility-preserving options | Enclomiphene; hCG (Injectable TRT + HCG plan) | Enclomiphene; clomiphene |
| Labs included? | At-home lab at intake (Kymata, secondary) | $65 initial biomarker test + consult [vendor 2026-10-25]; Premium retests every 3 months (Kymata) |
| Minimum term | 1, 3, 6 or 12-month plans | Month-to-month |
| Cancellation | Program payments non-refundable; cancel renewal before date (Kymata, secondary) | No commitments, cancel anytime; fees non-refundable, subscription auto-renews until cancelled [vendor 2026-10-25] |
| States | — | — |
| FDA warning letters | CONFIRMED on fda.gov: MARCS-CMS 730095, 8 Jun 2026, false/misleading claims re compounded semaglutide & tirzepatide (not TRT/enclomiphene). Closeout not published per pricetrackerglp1.com (14 Oct 2026). https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026 | — |
| Verified on clinic page | price, therapies, fertility_options, fda_warning_letters, legitscript seal (vendor pages, 2026-10-25); labs & cancellation secondary | price (membership), labs ($65), cancellation, legitscript seal (vendor pages, 2026-10-25); enclomiphene med price unverified |
Not medical advice. Checked 2026-10-25.